Permeation of blood-borne IL15 across the blood-brain barrier and the effect of LPS

Journal of Neurochemistry

Volumn 106, Issue 1, 2008, Pages 313-319

  Pan, Weihong ^a   Hsuchou, Hung ^a   Yu, Chuanhui ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Blood brain barrier; Interleukin15; Lipopolysaccharide; Neuroinflammation; Permeability

Indexed keywords

INTERLEUKIN 15; IODINE 125; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; SPINAL CORD;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOOD-BRAIN BARRIER; BRAIN; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; ENCEPHALITIS; INFLAMMATION MEDIATORS; INTERLEUKIN-15; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION;

MUS;

EID: 45249105985     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05390.x     Document Type: Article

References (34)

1. Banks W. A., Niehoff M. L. Zalcman S. S. (2004) Permeability of the mouse blood-brain barrier to murine interleukin-2: predominance of a saturable efflux system. Brain Behav. Immun. 18, 434 442.
2. Baslund B., Tvede N., Danneskiold-Samsoe B. et al. (2005) Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum. 52, 2686 2692.
3. Beck R. D. Jr, Wasserfall C., Ha G. K., Cushman J. D., Huang Z., Atkinson M. A. Petitto J. M. (2005) Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res. 1041, 223 230.
4. Cao X., Shores E. W., Hu-Li J. et al. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2, 223 238.
5. Fehniger T. A. Caligiuri M. A. (2001) Interleukin 15: biology and relevance to human disease. Blood 97, 14 32.
6. Hanisch U., Lyons S., Prinz M., Nolte C., Weber J., Kettenmann H. Kirchhoff F. (1997) Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J. Biol. Chem. 272, 28853 28860.
7. Kastin A. J., Akerstrom V. Pan W. (2001) Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls. Peptides 22, 2127 2136.
8. Kennedy M. K., Glaccum M., Brown S. N. et al. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771 780.
9. Kubota T., Brown R. A., Fang J. Krueger J. M. (2001) Interleukin-15 and interleukin-2 enhance non-REM sleep in rabbits. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1004 R1012.
10. Kurowska M., Rudnicka W., Maslinska D. Maslinski W. (2002) Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain. Ann. N Y Acad. Sci. 966, 441 445.
11. Lee Y. B., Satoh J., Walker D. G. Kim S. U. (1996) Interleukin-15 gene expression in human astrocytes and microglia in culture. NeuroReport 7, 1062 1066.
12. Lodolce J. P., Boone D. L., Chai S., Swain R. E., Dassopoulos T., Trettin S. Ma A. (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669 676.
13. McInnes I. B., al-Mughales J., Field M., Leung B. P., Huang F. P., Dixon R., Sturrock R. D., Wilkinson P. C. Liew F. Y. (1996) The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 2, 175 182.
14. McInnes I., Leung B., Sturrock R., Field M. Liew F. (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat. Med. 3, 189 195.
15. Pan W. Kastin A. J. (2003a) Interactions of cytokines with the blood-brain barrier: implications for feeding. Curr. Pharm. Des. 9, 827 831.
16. Pan W. Kastin A. J. (2003b) Transport of cytokines and neurotrophins across the BBB and their regulation after spinal cord injury, in Blood-Spinal Cord and Brain Barriers in Health and Disease (Shanker H. Westman J., eds pp. 395 407. Elsevier, Academic Press, San Diego, CA, USA.
17. Pan W., Banks W. A., Kennedy M. K., Gutierrez E. G. Kastin A. J. (1996) Differential permeability of the BBB in acute EAE: enhanced transport of TNF-α. Am. J. Physiol. 271, E636 E642.
18. Pan W., Banks W. A. Kastin A. J. (1997a) Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp. Neurol. 146, 367 373.
19. Pan W., Banks W. A. Kastin A. J. (1997b) Permeability of the blood-brain and blood-spinal cord barriers to interferons. J. Neuroimmunol. 76, 105 111.
20. Pan W., Banks W. A., Fasold M. B., Bluth J. Kastin A. J. (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmcol. 37, 1553 1561.
21. Pan W., Kastin A. J., Bell R. L. Olson R. D. (1999) Upregulation of tumor necrosis factor α transport across the blood-brain barrier after acute compressive spinal cord injury. J. Neurosci. 19, 3649 3655.
22. Pan W., Kastin A. J. Brennan J. M. (2000) Saturable entry of leukemia inhibitory factor from blood to the central nervous system. J. Neuroimmunol. 106, 172 180.
23. Pan W., Barron M., Hsuchou H., Tu H. Kastin A. J. (2008) Increased leptin permeation across the blood-brain barrier after chronic alcohol ingestion. Int. J. Neuropsychopharm. 33, 859 866.
24. Rentzos M., Cambouri C., Rombos A., Nikolaou C., Anagnostouli M., Tsoutsou A., Dimitrakopoulos A., Triantafyllou N. Vassilopoulos D. (2006) IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci. 241, 25 29.
25. Rose J. W., Burns J. B., Bjorklund J., Klein J., Watt H. E. Carlson N. G. (2007) Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology 69, 785 789.
26. Ruckert R., Brandt K., Braun A., Hoymann H. G., Herz U., Budagian V., Durkop H., Renz H. Bulfone-Paus S. (2005) Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J. Immunol. 174, 5507 5515.
27. Satoh J., Kurohara K., Yukitake M. Kuroda Y. (1998) Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J. Neurol. Sci. 155, 170 177.
28. Smith X. G., Bolton E. M., Ruchatz H., Wei X., Liew F. Y. Bradley J. A. (2000) Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J. Immunol. 165, 3444 3450.
29. Tu H., Pan W., Feucht L. Kastin A. J. (2007) Convergent trafficking pattern of leptin after endocytosis mediated by ObRa - ObRd. J. Cell. Physiol. 212, 215 222.
30. Waguespack P. L., Banks W. A. Kastin A. J. (1994) Interleukin-2 does not cross the blood-brain barrier by a saturable transport system. Brain Res. Bull. 34, 103 109.
31. Xaio H., Banks W. A., Niehoff M. L. Morley J. E. (2001) Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res. 896, 36 42.
32. Yu C., Kastin A. J., Ding Y. Pan W. (2007a) Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Exp. Neurol. 203, 116 122.
33. Yu C., Kastin A. J. Pan W. (2007b) TNF reduces LIF endocytosis despite increasing NFkappaB-mediated gp130 expression. J. Cell. Physiol. 213, 161 166.
34. Yu C., Kastin A. J., Tu H. Pan W. (2007c) Opposing effects of proteasomes and lysosomes on LIFR: modulation by TNF. J. Mol. Neurosci. 32, 80 89.